4dff: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
[[Image:4dff.png|left|200px]]
==The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia==
<StructureSection load='4dff' size='340' side='right' caption='[[4dff]], [[Resolution|resolution]] 2.11&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[4dff]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4DFF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4DFF FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0JP:8,9-DIMETHOXY-1-(1,3-THIAZOL-5-YL)-5,6-DIHYDROIMIDAZO[5,1-A]ISOQUINOLINE'>0JP</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PDE10A ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4dff FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4dff OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4dff RCSB], [http://www.ebi.ac.uk/pdbsum/4dff PDBsum]</span></td></tr>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/PDE10_HUMAN PDE10_HUMAN]] Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. Can hydrolyze both cAMP and cGMP, but has higher affinity for cAMP and is more efficient with cAMP as substrate.<ref>PMID:17389385</ref> 
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The identification of potent and orally active dihydroimidazoisoquinolines as PDE 10A inhibitors is reported. The SAR development led to the discovery of compound 35 as a potent, selective, and orally active PDE10A inhibitor. Compound 35 inhibited MK-801-induced hyperactivity at 3mg/kg and displayed a 10-fold separation between the minimal effective doses for inhibition of MK-801-induced hyperactivity and hypolocomotion in rats.


<!--
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia.,Ho GD, Michael Seganish W, Bercovici A, Tulshian D, Greenlee WJ, Van Rijn R, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R Bioorg Med Chem Lett. 2012 Feb 9. PMID:22377514<ref>PMID:22377514</ref>
The line below this paragraph, containing "STRUCTURE_4dff", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_4dff|  PDB=4dff  |  SCENE=  }}


===The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia===
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>


 
==See Also==
<!--
*[[Phosphodiesterase|Phosphodiesterase]]
The line below this paragraph, {{ABSTRACT_PUBMED_22377514}}, adds the Publication Abstract to the page
== References ==
(as it appears on PubMed at http://www.pubmed.gov), where 22377514 is the PubMed ID number.
<references/>
-->
__TOC__
{{ABSTRACT_PUBMED_22377514}}
</StructureSection>
 
==About this Structure==
[[4dff]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4DFF OCA].
 
==Reference==
<ref group="xtra">PMID:022377514</ref><references group="xtra"/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Bercovici, A.]]
[[Category: Bercovici, A]]
[[Category: Bleichardt, C.]]
[[Category: Bleichardt, C]]
[[Category: Greenlee, W J.]]
[[Category: Greenlee, W J]]
[[Category: Guzzi, M.]]
[[Category: Guzzi, M]]
[[Category: Ho, G D.]]
[[Category: Ho, G D]]
[[Category: Hodgson, R.]]
[[Category: Hodgson, R]]
[[Category: Hruza, A.]]
[[Category: Hruza, A]]
[[Category: Mullins, D.]]
[[Category: Mullins, D]]
[[Category: Rijn, R Van.]]
[[Category: Rijn, R Van]]
[[Category: Rindgen, D.]]
[[Category: Rindgen, D]]
[[Category: Seganish, W M.]]
[[Category: Seganish, W M]]
[[Category: Tulshian, D.]]
[[Category: Tulshian, D]]
[[Category: Xiao, L.]]
[[Category: Xiao, L]]
[[Category: Zhang, X.]]
[[Category: Zhang, X]]
[[Category: Hydrolase-hydrolase inhibitor complex]]
[[Category: Hydrolase-hydrolase inhibitor complex]]
[[Category: Mg binding]]
[[Category: Mg binding]]
[[Category: Zn binding]]
[[Category: Zn binding]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA